Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > business as usual...
View:
Post by sunshine7 on Jul 25, 2016 9:58am

business as usual...

cxr cannot control the share price without doing something stupid like share buy backs. Debt pay down is a priority. They can only manage their business to guidance as they have. There will always be competition but considering the diversity of the portfolio, individual product risks are minimal. For every under performance there is an over performing product, that is business as usual.
Comment by MirrorWorldMan on Jul 25, 2016 10:19am
Agreee, diversity in product lines bring long term rigor.  WRT moody, Increased competition for one drug by one competitor that had a FDA nod in one CXR exclusive marketing space in one country deserves a negative moody, and thats all.  BTW, the earnings transcript state that price increases are not a major source of revenue growth contribution and guidance. Volume growth at constant ...more  
Comment by LatticeInExile on Jul 25, 2016 11:18am
This post has been removed in accordance with Community Policy
Comment by sunshine7 on Jul 25, 2016 11:33am
why would insiders buy in the face of a giant short attack? They are investors too. They will buy when it turns around.
Comment by puma1 on Jul 25, 2016 11:35am
they can't buy while the Special comittee is reviewing strategies. it is a Blackout for insider buys
Comment by wallop13 on Jul 25, 2016 11:34am
They can't buy during a strategic review. You're a sc*mbag Lattice.
Comment by puma1 on Jul 25, 2016 11:37am
posted same thing Wallop - when you see them resorting to this level of disinformation just  to keep putting forward the short thesis , one has to think it will end in pain for them
Comment by LatticeInExile on Jul 25, 2016 12:00pm
This post has been removed in accordance with Community Policy
Comment by LatticeInExile on Jul 25, 2016 12:03pm
This post has been removed in accordance with Community Policy
Comment by GoldBug024 on Jul 25, 2016 12:11pm
Whens the last time google ceo last bought? AMAZON? McDonald's? You are crazy to think no insider buying for 8 months is a huge issue.
Comment by Craigbad on Jul 25, 2016 12:16pm
When the sp is hitting new 52 week lows and management is getting paid huge sums of cash instead of stock, this is a HUGE issue. The other companies mentioned don't have the huge cash compensation and are likely getting paid in options likely.
Comment by LatticeInExile on Jul 25, 2016 12:20pm
This post has been removed in accordance with Community Policy
Comment by wordless on Jul 25, 2016 11:36am
Any ideas why insiders aren't buying? Its almost 4 weeks after quarter end. Do you not think they have a good idea of what earnings will be by now? Is that not material information that is not available to the general public yet which would preclude them from buying as per insider trading rules? They have also not yet announce the end of the strategic alternative process. Would they also not ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities